Vijay Reddy

This inventor holds 2 USPTO granted patents. Top assignees: Scripps Research Institute, The Salk Institute. Active years: 2011-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vijay Reddy. Retrieved from https://idiyas.com/inventor/vijay-reddy-yuet115p

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 2(Granted Patents)

Company Filing History:

2 out of 1,208

Scripps Research Institute

where one patent can have more than one assignee

Years Active: 2011-2013

Loading Chart...

2 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8404247 - Antitoxin and vaccine platform based on nodavirus VLPS (2013-03-26),

2. 7998487 - Antitoxin and vaccine platform based on nodavirus VLPs (2011-08-16),

Title: Vijay Reddy: Innovator in Antitoxin and Vaccine Development

Introduction

Vijay Reddy is a prominent inventor based in San Diego, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antitoxins and vaccines. With a focus on innovative solutions, Reddy has been instrumental in advancing medical research.

Latest Patents

Vijay Reddy holds 2 patents related to his groundbreaking work. His latest patents include an antitoxin and vaccine platform based on nodavirus virus-like particles (VLPs). These patents provide compositions for anthrax antitoxins and vaccines, as well as methods for treating toxins with VLP-based antitoxins. Additionally, they outline methods for raising an immune response using immunogen-decorated VLPs.

Career Highlights

Throughout his career, Reddy has worked with esteemed institutions such as the Salk Institute for Biological Studies and the Scripps Research Institute. His work has been pivotal in the development of novel therapeutic approaches to combat various toxins and infectious diseases.

Collaborations

Some of his notable coworkers include John Young and Anette Schneemann. Their collaborative efforts have contributed to the advancement of research in the field of immunology and vaccine development.

Conclusion

Vijay Reddy's innovative work in antitoxin and vaccine development showcases his commitment to improving public health through scientific research. His contributions continue to influence the field and pave the way for future advancements.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]